A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02572167 · COMPLETED
Trial details
- NCT number
- NCT02572167
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-31
- Primary completion
- 2018-03-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.